MGMirjam A. F. M. Gerrits

Mirjam A. F. M. Gerrits

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mirjam A. F. M. Gerrits has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Alexis Bailey

    Division of Pharmacology, School of Health & Medical Sciences, City St George’s University of London, London, SW17 ORE, UK

    1 shared publication
  • Heidi M B Lesscher

    Department of Pharmacology and Anatomy, Rudolf Magnus Institute of Neuroscience, UMC Utrecht, Stratenum, Universiteitsweg 100, Utrecht, The Netherlands

    1 shared publication
  • Heidi M. B. Lesscher

    Rudolf Magnus Institute of Neuroscience, Department of Pharmacology and Anatomy, University Medical Center Utrecht, The Netherlands

    1 shared publication
  • Ian Kitchen

    Pharmacology Group, School of Biomedical and Life Sciences, University of Surrey, Guildford GU2 7XH, UK

    1 shared publication
  • J Peter H Burbach

    Department of Pharmacology and Anatomy, Rudolf Magnus Institute of Neuroscience, UMC Utrecht, Stratenum, Universiteitsweg 100, Utrecht, The Netherlands

    1 shared publication
  • J. Peter H. Burbach

    Rudolf Magnus Institute of Neuroscience, Department of Pharmacology and Anatomy, University Medical Center Utrecht, The Netherlands

    1 shared publication

Latest Publications

  • μ-Opioid Receptors are not Involved in Acute Cocaine-Induced Locomotor Activity nor in Development of Cocaine-Induced Behavioral Sensitization in Mice

    by Heidi M B Lesscher, Michiel Hordijk, Natalia P Bondar, Olga V Alekseyenko, J Peter H Burbach, Jan M van Ree, Mirjam A F M Gerrits

    Although -opioid receptors have been extensively investigated for their role in drug reinforcement, little is known about the contribution of these receptors to the acute and sensitized locomotor response to cocaine. In this study -opioid receptor involvement in acute cocaine-induced locomotor activity and in the development of cocaine-induced behavioral sensitization was evaluated using -opioid receptor knockout mice and chronic naltrexone (NTX) pretreatment as models. In addition, co-administration of the specific -opioid receptor antagonist CTOP with repeated saline or cocaine injections was used to establish the involvement of -opioid receptors in sensitization to the locomotor stimulant effects of cocaine. The acute locomotor response to cocaine (3, 10, 20, or 30 mg/kg i.p.) of -opioid receptor knockout or chronic NTX pretreated mice was not different from the cocaine response of their respective controls. With respect to cocaine-induced behavioral sensitization, induced by daily injections of 20 mg/kg cocaine for 11 subsequent days, -opioid receptor knockout mice developed behavioral sensitization to the locomotor stimulant effects of cocaine (challenge 10 mg/kg i.p.) comparable to wild-type littermates and the -opioid receptor antagonist CTOP did not affect cocaine-induced sensitization either. However, mice that were pretreated with NTX exhibited augmented cocaine-induced behavioral sensitization relative to placebo pretreated controls, which may be ascribed to increased -opioid receptor levels as has been described for chronic NTX pretreated mice. The present findings suggest that -opioid receptors are not required for the acute locomotor response to cocaine nor are they essential for the development of cocaine-induced behavioral sensitization.


  • Receptor‐selective changes in µ‐, δ‐ and κ‐opioid receptors after chronic naltrexone treatment in mice

    by Heidi M. B. Lesscher, Alexis Bailey, J. Peter H. Burbach, Jan M. Van Ree, Ian Kitchen, Mirjam A. F. M. Gerrits

    Chronic treatment with the opioid antagonist naltrexone induces functional supersensitivity to opioid agonists, which may be explained by receptor up-regulation induced by opioid receptor blockade. In the present study, the levels of opioid receptor subtypes through the brain of mice were determined after chronic naltrexone treatment using quantitative in vitro autoradiography. This is the first complete mapping study in mice for micro-, delta- and kappa-opioid receptors after chronic naltrexone exposure. Treatment with naltrexone clearly induced up-regulation of micro- (mean 80%) and, to a lesser extent, delta-opioid receptors (mean 39%). The up-regulation of micro- and delta-opioid receptors was evident throughout the brain, although there was variation in the percentage change across brain regions. In contrast, consistent up-regulation of kappa-opioid receptors was observed in cortical structures only and was not so marked as for micro- and delta-opioid receptors. In noncortical regions kappa-opioid receptor expression was unchanged. Taken together, the present findings suggest opioid receptor subtype-selective regulation by chronic naltrexone treatment in mice.